Singapore markets closed

Clover Biopharmaceuticals, Ltd. (2197.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.370+0.025 (+7.25%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
257
0
0
0
Operating expenses
Research development
995,662
1,465,324
1,826,301
228,219
Selling general and administrative
105,831
113,070
160,582
76,429
Total operating expenses
1,302,980
1,861,152
2,157,785
284,289
Operating income or loss
-1,302,925
-1,861,152
-2,157,785
-284,289
Interest expense
15,502
5,930
2,520
1,657
Income before tax
-665,194
-2,451,903
-6,016,303
-912,898
Income tax expense
0
0
0
0
Income from continuing operations
-665,194
-2,451,903
-6,016,303
-912,898
Net income
-665,194
-2,451,903
-6,016,303
-912,898
Net income available to common shareholders
-665,194
-2,451,903
-6,016,303
-912,898
Basic EPS
-0.65
-2.22
-13.02
-0.79
Diluted EPS
-0.65
-2.22
-13.02
-0.79
Basic average shares
1,179,166
1,102,104
462,117
1,158,115
Diluted average shares
1,182,010
1,102,104
462,117
1,158,115